Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Egner

Showing results (511-520 of 646) with videos related to

Pageof 65
Sort By:
Investigational New Drugs|January 1, 1994
Phase II trial of 6-thioguanine in advanced renal cell carcinoma. An Illinois Cancer Center studyD H Shevrin, L J Kilton, T E Lad, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|August 9, 2017
Specialist perioperative allergy clinic services in the UK 2016: Results from the Royal College of Anaesthetists Sixth National Audit ProjectW Egner, T Cook, N Harper, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 2019
Hydrogel-based transparent soils for root phenotyping in vivoLin Ma, Yichao Shi, Oskar Siemianowski, et al.
Advances in Experimental Medicine and Biology|January 1, 1995
New molecules on dendritic cells and their interactions with T lymphocytesD N Hart, G C Starling, W Egner, et al.
International Journal of Cardiology|April 2, 2023
Does sex affect the risk of 30-day all-cause mortality in cardiogenic shock?Alexander Schmitt, Tobias Schupp, Jonas Rusnak, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|November 24, 2023
Association of body mass index with 30-day all-cause mortality in cardiogenic shockAlexander Schmitt, Tobias Schupp, Jonas Rusnak, et al.
Internal and Emergency Medicine|May 9, 2025
Partial arterial carbon dioxide and oxygen pressure in patients with cardiogenic shockJonas Rusnak, Tobias Schupp, Kathrin Weidner, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 1, 1997
Predictive value of molecular dosimetry: individual versus group effects of oltipraz on aflatoxin-albumin adducts and risk of liver cancerT W Kensler, S J Gange, P A Egner, et al.
Translational Vision Science & Technology|November 17, 2021
Identification of Subclinical Microvascular Biomarkers in Coronary Heart Disease in Retinal ImagingJulia Aschauer, Stefan Aschauer, Andreas Pollreisz, et al.
Clinical Laboratory|October 16, 2023
D-Dimer Levels and the Risk of 30-Day All-Cause Mortality in Cardiogenic Shock Stratified by EtiologyTobias Schupp, Michael Behnes, Jonas Rusnak, et al.
Pageof 65

Showing results (511-520 of 646) with videos related to

Sort By:
Pageof 65
Investigational New Drugs|January 1, 1994
Phase II trial of 6-thioguanine in advanced renal cell carcinoma. An Illinois Cancer Center studyD H Shevrin, L J Kilton, T E Lad, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|August 9, 2017
Specialist perioperative allergy clinic services in the UK 2016: Results from the Royal College of Anaesthetists Sixth National Audit ProjectW Egner, T Cook, N Harper, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 2019
Hydrogel-based transparent soils for root phenotyping in vivoLin Ma, Yichao Shi, Oskar Siemianowski, et al.
Advances in Experimental Medicine and Biology|January 1, 1995
New molecules on dendritic cells and their interactions with T lymphocytesD N Hart, G C Starling, W Egner, et al.
International Journal of Cardiology|April 2, 2023
Does sex affect the risk of 30-day all-cause mortality in cardiogenic shock?Alexander Schmitt, Tobias Schupp, Jonas Rusnak, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|November 24, 2023
Association of body mass index with 30-day all-cause mortality in cardiogenic shockAlexander Schmitt, Tobias Schupp, Jonas Rusnak, et al.
Internal and Emergency Medicine|May 9, 2025
Partial arterial carbon dioxide and oxygen pressure in patients with cardiogenic shockJonas Rusnak, Tobias Schupp, Kathrin Weidner, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 1, 1997
Predictive value of molecular dosimetry: individual versus group effects of oltipraz on aflatoxin-albumin adducts and risk of liver cancerT W Kensler, S J Gange, P A Egner, et al.
Translational Vision Science & Technology|November 17, 2021
Identification of Subclinical Microvascular Biomarkers in Coronary Heart Disease in Retinal ImagingJulia Aschauer, Stefan Aschauer, Andreas Pollreisz, et al.
Clinical Laboratory|October 16, 2023
D-Dimer Levels and the Risk of 30-Day All-Cause Mortality in Cardiogenic Shock Stratified by EtiologyTobias Schupp, Michael Behnes, Jonas Rusnak, et al.
Pageof 65